clinicaltrials.gov
Kanál RSS pre ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days
Získajte najnovšie aktualizácie z ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days hneď, ako vyjdú.
Najnovšie príspevky
Sledujte ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days tam, kde čítate
Ľudia, ktorí sledujú ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days, sledujú aj
-
Chugai Pharmaceutical: News Releases chugai-pharm.co.jp
-
What's new ema.europa.eu
-
Roche Media News roche.com
Otázky
Aká je adresa RSS kanála pre ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days?
Adresa kanála je https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=adalimumab&recrs=abdf&type=Intr&phase=01234&fund=2&count=10000. Vložte ju do ľubovoľnej RSS čítačky alebo kliknite na Sledovať teraz a čítajte ho v službe Feeder.
Ako často publikuje ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days?
ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days publikuje približne 2-krát týždenne. Posledný príspevok bol zverejnený pred dňom.
Funguje RSS kanál ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days?
Áno. Feeder ho skontroloval pred asi hodinou a kanál odpovedal normálne.
Ako môžem sledovať ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days v službe Feeder?
Kliknite na Sledovať teraz a ak ešte nemáte účet, zaregistrujte sa. Bezplatný plán Feeder zahŕňa až 200 kanálov na webe, iPhone a Androide. Platobná karta nie je potrebná.
Sledovať ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days v aplikácii Feeder
Bezplatný plán Feeder zahŕňa až 200 kanálov na webe, iPhone a Androide. Platobná karta nie je potrebná.